National academies’s initial report on biodefense & synbio – PLoS Blogs (blog)
PLoS Blogs (blog) |
National academies’s initial report on biodefense & synbio
PLoS Blogs (blog) The National Academies of Sciences, Engineering, and Medicine are working to develop a report on security concerns around synthetic biology. The committee recently put out its initial report, “A Proposed Framework For Identifying Potential Biodefense … |
Futurism |
A “Fourth-Generation” DNA Base Editor Could Replace CRISPR
Futurism The latest news in genetic science has been dominated by the CRISPR/Cas9 technique over the past five years. But a new “fourth-generation” DNA base editor could see CRISPR dethroned, according to a recent study published in Science Advances. |
Futurism |
A “Fourth-Generation” DNA Base Editor Could Replace CRISPR
Futurism The latest news in genetic science has been dominated by the CRISPR/Cas9 technique over the past five years. But a new “fourth-generation” DNA base editor could see CRISPR dethroned, according to a recent study published in Science Advances. |
|
FDA crackdown on unproven stem cell therapies
BioNews The US Food and Drug Administration (FDA) has announced its intention to investigate the use of unproven stem cell therapies being offered in the country’s clinics. Tighter enforcement from the FDA comes as an inspection at StemImmune Inc based in San … |
|
FDA crackdown on unproven stem cell therapies
BioNews The US Food and Drug Administration (FDA) has announced its intention to investigate the use of unproven stem cell therapies being offered in the country’s clinics. Tighter enforcement from the FDA comes as an inspection at StemImmune Inc based in San … |
The Pharma Letter (registration) |
Biotech with exciting gene therapy climbs 50% in a week
The Pharma Letter (registration) US gene therapy developer Abeona Therapeutics (Nasdaq: ABEO) is set to start trading on Monday with a share price worth around $13.60, more than 50% higher than it was a week ago. It comes amid excitement at the potential of Abeona’s EB-101 gene … |